Jan. 7 at 2:03 AM
$WKSP The Nasdaq includes many early‑stage, growth‑oriented, and speculative companies, especially in biotech and tech.
A large share of these firms operate at a loss, often for many years, because their business models emphasize growth over profitability.
On the Nasdaq, approximately 3,300 companies are listed, but only a small fraction of these companies turn a profit consistently.
